These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9988067)

  • 1. Increased pertechnegas lung clearance in interstitial lung disease.
    Mouratidis B; Lising J; Nogrady S; Hurwitz M
    Clin Nucl Med; 1999 Feb; 24(2):105-8. PubMed ID: 9988067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertechnegas lung clearance in different forms of interstitial lung disease.
    Thomeer MJ; Dehaes B; Mortelmans L; Demedts M
    Eur Respir J; 2002 Jan; 19(1):31-6. PubMed ID: 11843324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of lung clearance of inhaled pertechnegas.
    Fanti S; Compagnone G; Pancaldi D; Franchi R; Corbelli C; Marengo M; Onofri C; Galassi R; Levorato M; Monetti N
    Ann Nucl Med; 1996 Feb; 10(1):147-51. PubMed ID: 8814721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physicochemical characterization and lung clearance of pertechnegas].
    Tominaga S; Shimada T; Kawakami K; Yoshizawa Y
    Kaku Igaku; 1995 Jun; 32(6):563-7. PubMed ID: 7674566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation of pertechnegas: similar clearance from the lungs to that of inhaled pertechnetate aerosol.
    Isawa T; Teshima T; Anazawa Y; Miki M; Mahmud AM
    Nucl Med Commun; 1995 Sep; 16(9):741-6. PubMed ID: 7478406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD).
    Bodolay E; Szekanecz Z; Dévényi K; Galuska L; Csípo I; Vègh J; Garai I; Szegedi G
    Rheumatology (Oxford); 2005 May; 44(5):656-61. PubMed ID: 15716315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical properties and use of pertechnegas as a ventilation agent.
    Mackey DW; Jackson P; Baker RJ; Dasaklis C; Fisher KJ; Magee M; Bush V; Burch WM; Van der Wall H; Willett GD
    J Nucl Med; 1997 Jan; 38(1):163-7. PubMed ID: 8998172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution electron microscopy of technegas and pertechnegas.
    Isawa T; Lee BT; Hiraga K
    Nucl Med Commun; 1996 Feb; 17(2):147-52. PubMed ID: 8778639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alveolar permeability in patients with diffuse infiltrative lung disease detected by Tc-99m DTPA radioaerosol inhalation lung scintigraphy and the relationships with the pulmonary function test.
    Wang SJ; Kao CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Oct; 56(4):264-9. PubMed ID: 8548669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimentally produced pulmonary arterial occlusion in the dog: identification with pertechnegas inhalation.
    Scalzetti EM; Grossman ZD; Gagne GM
    Radiology; 1993 Feb; 186(2):423-6. PubMed ID: 8380648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A compartmental model for alveolar clearance of pertechnegas.
    Kotzerke J; van den Hoff J; Burchert W; Wagner TF; Emter M; Hundeshagen H
    J Nucl Med; 1996 Dec; 37(12):2066-71. PubMed ID: 8970536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technegas and Pertechnegas particle size distribution.
    Lloyd JJ; Shields RA; Taylor CJ; Lawson RS; James JM; Testra HJ
    Eur J Nucl Med; 1995 May; 22(5):473-6. PubMed ID: 7641756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m labeled micro aerosol "Pertechnegas". A new agent for ventilation imaging in suspected pulmonary emboli.
    Ashburn WL; Belezzuoli EV; Dillon WA; Mensh BD; Hoogland D; Yeung DW; Coade GE
    Clin Nucl Med; 1993 Dec; 18(12):1045-52. PubMed ID: 8293624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.
    Raghu G; Mageto YN; Lockhart D; Schmidt RA; Wood DE; Godwin JD
    Chest; 1999 Nov; 116(5):1168-74. PubMed ID: 10559072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot trial of quantitative Tc-99m HMPAO and Ga-67 citrate lung scans to detect pulmonary vascular endothelial damage and lung inflammation in patients of collagen vascular diseases with active diffuse infiltrative lung disease.
    Hang LW; Hsu WH; Tsai JJ; Jim YF; Lin CC; Kao A
    Rheumatol Int; 2004 May; 24(3):153-6. PubMed ID: 12838367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of chest background on pulmonary 99mTc-DTPA clearance in interstitial lung disease.
    Ishizaka A; Kanazawa M; Suzuki Y; Hasegawa N; Kubo A; Kawashiro T
    J Appl Physiol (1985); 1992 Nov; 73(5):1820-4. PubMed ID: 1474057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transition from technegas to pertechnegas.
    Scalzetti EM; Gagne GM
    J Nucl Med; 1995 Feb; 36(2):267-9. PubMed ID: 7830129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of different scintigraphic approaches to assess pulmonary ventilation.
    Magnant J; Vecellio L; de Monte M; Grimbert D; Valat C; Boissinot E; Guilloteau D; Lemarié E; Diot P
    J Aerosol Med; 2006; 19(2):148-59. PubMed ID: 16796539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of alveolar permeability and lung inflammation in patients with active diffuse infiltrative lung disease detected by 99Tcm-DTPA radioaerosol inhalation lung scintigraphy and quantitative 67Ga lung scans.
    Kao CH; Lin HT; Yu SL; Wang SJ; Yeh SH
    Nucl Med Commun; 1994 Oct; 15(10):850-4. PubMed ID: 7838450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of radiopharmaceutical delivered from 99mTc-DTPA in the technegas generator].
    Dohi M; Moriya E; Mori Y; Kawakami K; Yoshizawa Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jan; 56(1):48-52. PubMed ID: 8857099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.